Two-year results of a randomized controlled trial of rifampicin-bonded extra-anatomic Dacron grafts

British Journal of Surgery

Volumn 87, Issue 6, 2000, Pages 758-759

  Earnshaw, J J ^a   Whitman, B ^b   Heather, B P ^b  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DACRON; RIFAMPICIN;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTITUBERCULAR; BLOOD VESSEL PROSTHESIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POLYETHYLENE TEREPHTHALATES; RIFAMPIN; SURGICAL WOUND DEHISCENCE; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 0034047330     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2000.01490.x     Document Type: Conference Paper

References (5)

1. 1 Braithwaite BD, Davies B, Heather BP, Earnshaw JJ, Joint Vascular Research Group. Early results of a randomized trial of rifampicin-bonded Dacron grafts for extra-anatomic vascular reconstruction. Br J Surg 1998; 85: 1378-81.
2. 2 D'Addato M, Curti T, Freyrie A, Italian Investigators Group. Prophylaxis of graft infection with rifampicin-bonded Gelseal graft: 2-year follow-up of a prospective clinical trial. Cardiovasc Surg 1996; 4: 200-4.
3. 3 D'Addato M, Curti T, Freyrie A. The rifampicin-bonded Gelseal graft. Eur J Vasc Endovasc Surg 1997; 14(Suppl A): 15-17.
4. 4 Vicaretti M, Hawthorne WJ, Ao PY, Fletcher JP. An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge. Cardiovasc Surg 1998; 6: 268-73.
5. 5 Strachan CJL. Antibacterial prophylaxis in peripheral vascular and orthopaedic prosthetic surgery. J Antimicrob Chemother 1993; 31(Suppl B): 65-78.